Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night ... (ia when a middle of the nightawakening i...)

HOME >> MEDICINE >> TECHNOLOGY

Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings

Date:10/1/2008

ia when a middle of the night awakening is followed by difficulty returning to sleep. Phase 3 clinical trials have been completed for Intermezzo(R) and Transcept submitted an NDA to the FDA via the 505(b)(2) pathway on September 30, 2008.

For further information, please visit the company's website at: http://www.transcept.com.

About Novacea

Novacea, Inc. is a biopharmaceutical company that had been focused on in-licensing, developing and commercializing novel cancer therapies. Novacea has two product candidates, including Asentar(TM), which had been in a Phase 3 clinical trial for androgen-independent prostate cancer, and AQ4N, a hypoxia-activated prodrug. There are currently no clinical trials planned or underway for either candidate.

Safe Harbor

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Transcept and Novacea disclaim any intent or obligation to update these forward-looking statements, and claim the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, the expected timing of closing the merger, the expected cash balance of the combined entity as of the closing, the sufficiency of post closing cash to fund development of Intermezzo(R) through planned commercialization and the potential markets and expected benefits of Transcept product candidates. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, failure of Novacea stockholders to approve the merger; Novacea or Transcept inability to satisfy the conditions of the merger, or that the merger is otherwise delayed or ultimately not consummated; the rates of use of Transcept and Novacea cash and cash equivalents prior to the clos
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Critical Pharmaceuticals Enter Sustained Release hGH Arena
3. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
4. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
5. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
6. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
7. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
8. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
9. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
10. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
11. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients

Post Your Comments:

(Date:5/21/2013)... , May 21, 2013 IsoRay, Inc. (AMEX: ... it has entered into an exclusive international distribution agreement ... product line in Greece . IsoRay ... brachytherapy and medical radioisotope applications for brain cancer, lung ... ("gyn") cancer. IASIS Medical is ideally ...

(Date:5/21/2013)... , May 21, 2013 iHealth Lab ... of wireless personal healthcare products and a powerful ... announcing the release of two new fitness products ... monitors and scales: the Wireless Pulse Oximeter and ... http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth Lab ...

(Date:5/21/2013)... HILLS, N.Y. , May 21, 2013 The ... monitoring system used to measure hand-washing compliance at North ... , by introducing cameras in operating rooms at ... (Photo: http://photos.prnewswire.com/prnh/20130521/NY17810 ) The new pilot ... feedback in their operating rooms (ORs), the first time ...

Breaking Medicine Technology:IsoRay Announces A New International Distributor For Greece 2 IsoRay Announces A New International Distributor For Greece 3 iHealth Lab adds new products and partners to mobile personal healthcare offering 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3 North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4

[0] IsoRay Announces A New International Distributor For Greece [0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs

... Reportlinker.com announces that a new ... its catalogue: ... BRICS (Brazil, Russia, India, China, South ... http://www.reportlinker.com/p0704011/Nuclear-Imaging-Equipment-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...

... VIEW, Calif., Dec. 13, 2011 IRIDEX Corporation (Nasdaq: ... National Institute for Health and Clinical Excellence (NICE) has ... drug Lucentis is not as cost effective as conventional ... as a treatment for diabetic macular edema (DME), a ...

Nuclear Imaging Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema

(Date:5/21/2013)... DC (PRWEB) May 21, 2013 Two ... Benefits Guidance (SBG) will identify which strategies can be ... ensuring high-quality care to the members who are taking ... Information Services, Inc., “How to Manage Specialty Drugs ... Specialty pharmaceuticals are now the main driver for rising ...

(Date:5/21/2013)... The American Diabetes Association ( http://goo.gl/YRSF1 ... United States of America are affected with peripheral neuropathy. ... risk of developing peripheral neuropathy which unfortunately makes it ... further goes on saying that the disease usually affects ... million new cases are diagnosed every year in the ...

(Date:5/21/2013)... By Steven Reinberg HealthDay Reporter , , TUESDAY, ... it comes to steroid therapy for patients having severe ... Swiss investigators. Five days of glucocorticoid treatment with ... the standard 14 days, but with fewer chances for ... show that a shorter period of treatment was not ...

(Date:5/21/2013)... that it is a Grand Challenges Explorations winner, ... Gates Foundation. Tae Seok Moon, PhD, assistant professor ... an innovative global health and development research project ... Organisms." , Grand Challenges Explorations (GCE) funds individuals ... mold in how we solve persistent global health ...

(Date:5/21/2013)... of Mexican young adults may have a genetic predisposition ... conducted a study at the Universidad Autnoma de San ... factors from both parents were already 15 pounds heavier ... who hadn,t. They also had slightly higher fasting glucose ... of food science and human nutrition. , In the ...

Breaking Medicine News(10 mins):Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2 Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2 Health News:COPD Patients May Do Fine With Shorter Course of Steroids 2 Health News:COPD Patients May Do Fine With Shorter Course of Steroids 3 Health News:Gates Fellowship addresses parasite infection in developing world 2 Health News:Genetic risk for obesity found in many Mexican young adults 2

[0] Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar [0] Neuracel Aims to Reduce Peripheral Neuropathy Pain [0] COPD Patients May Do Fine With Shorter Course of Steroids [0] Gates Fellowship addresses parasite infection in developing world [0] Genetic risk for obesity found in many Mexican young adults

... Infrastructure ... ... a leading provider of comprehensive services for the planning,development and ... subsidiary of Fortress International,Group (Nasdaq: FIGI ), today announced ...

... discovered a way of diagnosing pre-eclampsia, a condition which affects ... to 15% of all premature deliveries. , They now plan ... could be used in hospitals all over the world to ... of a predictor for the NHS alone has been estimated ...

... of world,s biological manufacturing capacity is in Puerto Rico, ... the world,s,biotechnology manufacturing capacity is located in Puerto Rico, ... Over the past four years, more than $4 ... such giants as Eli Lilly, Amgen, Abbot,Ortho Biologics, BD ...

... the University of Delaware have discovered a novel technique--that ... the DNA code--to repair the defective gene that causes ... the number-one genetic killer of children under two years ... most severe form of the disease, can,t walk, crawl, ...

... newest reseller ... microphone, MAYNARD, Mass., Feb. 12 Revolabs, ... collaboration, today announced,that the Dictaphone Healthcare Solutions division ... Microphone alongside its Dragon(R),NaturallySpeaking(R) Medical speech recognition software ...

... Dr. Frank Stanton, Former President of CBS, BOSTON, ... has received a $3 million grant from The Stanton ... 109-year-old history.,The Stanton Foundation was created upon the death ... CBS and a noted philanthropist., , To view ...

Cached Medicine News:Health News:Total Site Solutions to Exhibit at HIMSS Conference 2 Health News:Total Site Solutions to Exhibit at HIMSS Conference 3 Health News:Total Site Solutions to Exhibit at HIMSS Conference 4 Health News:Breakthrough in pre-eclampsia test 2 Health News:Opportunities to Invest in Puerto Rico as Global Center for Biotechnology 2 Health News:UD researchers discover promising technique for repairing gene that causes spinal muscular atrophy 2 Health News:UD researchers discover promising technique for repairing gene that causes spinal muscular atrophy 3 Health News:UD researchers discover promising technique for repairing gene that causes spinal muscular atrophy 4 Health News:Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance 2 Health News:Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance 3 Health News:Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs 2 Health News:Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs 3

Total Site Solutions to Exhibit at HIMSS Conference Breakthrough in pre-eclampsia test Opportunities to Invest in Puerto Rico as Global Center for Biotechnology UD researchers discover promising technique for repairing gene that causes spinal muscular atrophy Revolabs xTag(TM) Wireless Microphone Now Offered as a Total Solution With Dragon(R) NaturallySpeaking(R) Medical Software from Nuance Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs

... The Rapidpoint 400 is a sophisticated whole ... for point-of-care testing while also satisfying the ... single, multiple-use measurement cartridge contains all of ... This long-lasting cartridge includes the sampling unit, ...

The AVL Omni modular system is a complete blood gas solution designed for high-volume critical care use, with customized test combinations, minimum intervention and flexibility....

... Sorvall DiscoveryTMM150 SE Micro-ultra centrifuge continues ... volume sample processing, now with 1,048,000 x ... bucket rotor. DiscoveryTMM150SE processes sample sizes ... a small floor footprint, brushless direct drive, ...

... 694,000 x g at speeds ... Coulter's Optima L-90K Ultracentrifuge enables ... in less time. This versatile ... broad range of superb rotors, ...

Medicine Products:

Rapidpoint 400 AVL OMNI Modular System Discovery M150 SE Microultracentrifuge Optima L-90 K Ultracentrifuge 60/50 Hz, 220-240 VAC